TY  - JOUR
T1  - REsearchers worry about myopathy risk for patients taking high-dose simvastatin
AU  - Mitka M
Y1  - 2009/01/21
N1  - 10.1001/jama.2008.939
JO  - JAMA
SP  - 261
EP  - 262
VL  - 301
IS  - 3
N2  - 
The negative appraisal of high-dose simvastatin was prompted by new results from the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH), presented at the Scientific Sessions of the American Heart Association held here in November.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2008.939
UR  - http://dx.doi.org/10.1001/jama.2008.939
ER  -